Griseofulvin-forte en es it fr

Griseofulvin-forte Brand names, Griseofulvin-forte Analogs

Griseofulvin-forte Brand Names Mixture

  • No information avaliable

Griseofulvin-forte Chemical_Formula


Griseofulvin-forte RX_link

Griseofulvin-forte fda sheet

Griseofulvin-forte msds (material safety sheet)

Griseofulvin-forte MSDS

Griseofulvin-forte Synthesis Reference

No information avaliable

Griseofulvin-forte Molecular Weight

352.766 g/mol

Griseofulvin-forte Melting Point

220 oC

Griseofulvin-forte H2O Solubility

8.64 mg/L

Griseofulvin-forte State


Griseofulvin-forte LogP


Griseofulvin-forte Dosage Forms

Powder; Tablet

Griseofulvin-forte Indication

For the treatment of ringworm infections of the skin, hair, and nails, namely: tinea corporis, tinea pedis, tinea cruris, tinea barbae, cradle cap or other conditions caused by Trichophyton or Microsporum fungi.

Griseofulvin-forte Pharmacology

Griseofulvin is a mycotoxic metabolic product of Penicillium spp. It was the first available oral agent for the treatment of dermatophytoses and has now been used for more than forty years. Griseofulvin is fungistatic with in vitro activity against various species of Microsporum Epidermophyton, and Trichophyton. It has no effect on bacteria or on other genera of fungi. Following oral administration, griseofulvin is deposited in the keratin precursor cells and has a greater affinity for diseased tissue. The drug is tightly bound to the new keratin which becomes highly resistant to fungal invasions.

Griseofulvin-forte Absorption

Poorly absorbed from GI ranging from 25 to 70% of an oral dose. Absorption is significantly enhanced by administration with or after a fatty meal.

Griseofulvin-forte side effects and Toxicity

Side effects are minor: headaches, gastrointestinal reactions and cutaneous eruptions

Griseofulvin-forte Patient Information

Griseofulvin-forte Organisms Affected

Yeast and other Trichophyton or Microsporum fungi